This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sanchez-Irizarry, C. Articles by Blacklow, S. C. Search for Related Content PubMed PubMed Citation Articles by Sanchez-Irizarry, C. Articles by Blacklow, S. C.

Notch Subunit Heterodimerization and Prevention of Ligand-Independent Proteolytic Activation Depend, Respectively, on a Novel Domain and the LNR Repeats

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts,¹ Department of Pathology and Laboratory Medicine, Institute for Medicine and Engineering, The Abramson Family Cancer Research Institute, University of Pennsylvania Medical School, Philadelphia, Pennsylvania²

Received 7 May 2004/ Returned for modification 15 June 2004/ Accepted 30 July 2004

Notch proteins are transmembrane receptors that participate in a highly conserved signaling pathway that regulates morphogenesis in metazoans. Newly synthesized Notch receptors are proteolytically cleaved during transit to the cell surface, creating heterodimeric mature receptors comprising noncovalently associated extracellular (N^EC) and transmembrane (N^TM) subunits. Ligand binding activates Notch by inducing two successive proteolytic cleavages, catalyzed by metalloproteases and gamma-secretase, respectively, that permit the intracellular portion of N^TM to translocate to the nucleus and activate transcription of target genes. Prior work has shown that the presence of N^EC prevents ligand-independent activation of N^TM, but the mechanisms involved are poorly understood. Here, we define the roles of two regions at the C-terminal end of N^EC that participate in maintaining the integrity of resting Notch receptors through distinct mechanisms. The first region, a hydrophobic, previously uncharacterized portion of N^EC, is sufficient to form stable complexes with the extracellular portion of N^TM. The second region, consisting of the three Lin12/Notch repeats, is not needed for heterodimerization but acts to protect N^TM from ligand-independent cleavage by metalloproteases. Together, these two contiguous regions of N^EC impose crucial restraints that prevent premature Notch receptor activation.

This article has been cited by other articles:

• De Keersmaecker, K., Lahortiga, I., Mentens, N., Folens, C., Van Neste, L., Bekaert, S., Vandenberghe, P., Odero, M. D., Marynen, P., Cools, J. (2008). In vitro validation of {gamma}-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. haematol 93: 533-542 [Abstract] [Full Text]  
• Li, K., Li, Y., Wu, W., Gordon, W. R., Chang, D. W., Lu, M., Scoggin, S., Fu, T., Vien, L., Histen, G., Zheng, J., Martin-Hollister, R., Duensing, T., Singh, S., Blacklow, S. C., Yao, Z., Aster, J. C., Zhou, B.-B. S. (2008). Modulation of Notch Signaling by Antibodies Specific for the Extracellular Negative Regulatory Region of NOTCH3. J. Biol. Chem. 283: 8046-8054 [Abstract] [Full Text]  
• Mansour, M. R., Duke, V., Foroni, L., Patel, B., Allen, C. G., Ancliff, P. J., Gale, R. E., Linch, D. C. (2007). Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia. Clin. Cancer Res. 13: 6964-6969 [Abstract] [Full Text]  
• Spaulding, C., Reschly, E. J., Zagort, D. E., Yashiro-Ohtani, Y., Beverly, L. J., Capobianco, A., Pear, W. S., Kee, B. L. (2007). Notch1 co-opts lymphoid enhancer factor 1 for survival of murine T-cell lymphomas. Blood 110: 2650-2658 [Abstract] [Full Text]  
• Fiuza, U.-M., Arias, A. M. (2007). Cell and molecular biology of Notch. J Endocrinol 194: 459-474 [Abstract] [Full Text]  
• Niessen, K., Karsan, A. (2007). Notch signaling in the developing cardiovascular system. Am. J. Physiol. Cell Physiol. 293: C1-C11 [Abstract] [Full Text]  
• Weyer, K., Boldt, H. B., Poulsen, C. B., Kjaer-Sorensen, K., Gyrup, C., Oxvig, C. (2007). A Substrate Specificity-determining Unit of Three Lin12-Notch Repeat Modules Is Formed in Trans within the Pappalysin-1 Dimer and Requires a Sequence Stretch C-terminal to the Third Module. J. Biol. Chem. 282: 10988-10999 [Abstract] [Full Text]  
• Nichols, J. T., Miyamoto, A., Olsen, S. L., D'Souza, B., Yao, C., Weinmaster, G. (2007). DSL ligand endocytosis physically dissociates Notch1 heterodimers before activating proteolysis can occur. J. Cell Biol. 176: 445-458 [Abstract] [Full Text]  
• Ehebauer, M., Hayward, P., Martinez-Arias, A. (2006). Notch Signaling Pathway. Sci Signal 2006: cm7-cm7 [Abstract] [Full Text]  
• Breit, S., Stanulla, M., Flohr, T., Schrappe, M., Ludwig, W.-D., Tolle, G., Happich, M., Muckenthaler, M. U., Kulozik, A. E. (2006). Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 108: 1151-1157 [Abstract] [Full Text]  
• Chiang, M. Y., Xu, M. L., Histen, G., Shestova, O., Roy, M., Nam, Y., Blacklow, S. C., Sacks, D. B., Pear, W. S., Aster, J. C. (2006). Identification of a Conserved Negative Regulatory Sequence That Influences the Leukemogenic Activity of NOTCH1.. Mol. Cell. Biol. 26: 6261-6271 [Abstract] [Full Text]  
• Weng, A. P., Millholland, J. M., Yashiro-Ohtani, Y., Arcangeli, M. L., Lau, A., Wai, C., del Bianco, C., Rodriguez, C. G., Sai, H., Tobias, J., Li, Y., Wolfe, M. S., Shachaf, C., Felsher, D., Blacklow, S. C., Pear, W. S., Aster, J. C. (2006). c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 20: 2096-2109 [Abstract] [Full Text]  
• Malecki, M. J., Sanchez-Irizarry, C., Mitchell, J. L., Histen, G., Xu, M. L., Aster, J. C., Blacklow, S. C. (2006). Leukemia-Associated Mutations within the NOTCH1 Heterodimerization Domain Fall into at Least Two Distinct Mechanistic Classes. Mol. Cell. Biol. 26: 4642-4651 [Abstract] [Full Text]  
• Zhu, Y.-M., Zhao, W.-L., Fu, J.-F., Shi, J.-Y., Pan, Q., Hu, J., Gao, X.-D., Chen, B., Li, J.-M., Xiong, S.-M., Gu, L.-J., Tang, J.-Y., Liang, H., Jiang, H., Xue, Y.-Q., Shen, Z.-X., Chen, Z., Chen, S.-J. (2006). NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis.. Clin. Cancer Res. 12: 3043-3049 [Abstract] [Full Text]  
• Reschly, E. J., Spaulding, C., Vilimas, T., Graham, W. V., Brumbaugh, R. L., Aifantis, I., Pear, W. S., Kee, B. L. (2006). Notch1 promotes survival of E2A-deficient T cell lymphomas through pre-T cell receptor-dependent and -independent mechanisms. Blood 107: 4115-4121 [Abstract] [Full Text]  
• Miyamoto, A., Lau, R., Hein, P. W., Shipley, J. M., Weinmaster, G. (2006). Microfibrillar Proteins MAGP-1 and MAGP-2 Induce Notch1 Extracellular Domain Dissociation and Receptor Activation. J. Biol. Chem. 281: 10089-10097 [Abstract] [Full Text]  
• Ladi, E., Nichols, J. T., Ge, W., Miyamoto, A., Yao, C., Yang, L.-T., Boulter, J., Sun, Y. E., Kintner, C., Weinmaster, G. (2005). The divergent DSL ligand Dll3 does not activate Notch signaling but cell autonomously attenuates signaling induced by other DSL ligands. J. Cell Biol. 170: 983-992 [Abstract] [Full Text]  
• Armstrong, S. A., Look, A. T. (2005). Molecular Genetics of Acute Lymphoblastic Leukemia. JCO 23: 6306-6315 [Abstract] [Full Text]